The Fungicide Propiconazole Induces Hepatic Steatosis and Activates PXR in a Mouse Model of Diet-induced Obesity

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 2024 Dec 24

PMID 39718591

Authors

Brecht Attema

Outi Kummu

Maria Krutakova

Petr Pavek

Jukka Hakkola

Guido J E J Hooiveld

Sander Kersten

Affiliations

Soon will be listed here.

Abstract

Propiconazole is a triazole fungicide previously shown to induce triglyceride accumulation in human liver HepaRG cells, potentially via activation of the Pregnane X Receptor (PXR). However, whether propiconazole can disrupt hepatic and whole-body metabolism in vivo is currently unknown. Therefore, we aimed to examine the metabolic effects of propiconazole in the context of metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, and insulin resistance. To this end, male C57BL/6J mice were fed a high-fat diet for 20 weeks. During the last 10 weeks, mice additionally received vehicle, 0.04, 30, or 100 mg/kg body weight (bw)/day propiconazole via oral gavage. High-dose propiconazole, but not low or intermediate dose, reduced body weight gain and adipose tissue weight in obese mice. Mice receiving high-dose propiconazole displayed improved glucose tolerance and reduced levels of plasma triglycerides and cholesterol. Propiconazole dose-dependently increased liver weight and triglyceride levels and at high dose caused signs of hepatic inflammation. RNA sequencing on the liver revealed that propiconazole mainly induced PXR target genes. At intermediate and high dose, propiconazole induced pathways related to cell-cell interactions and inflammation, while oxidative phosphorylation was repressed by propiconazole. Comparison of gene regulation in wildtype and PXR knockout primary hepatocytes as well as gene reporter assays confirmed the activation of PXR by propiconazole. All in all, our data underscore the capacity of propiconazole to activate PXR in the liver and thereby promote the development of hepatic steatosis in vivo.

References

Aleksunes L, Klaassen C . Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice. Drug Metab Dispos. 2012; 40(7):1366-79. PMC: 3382842. DOI: 10.1124/dmd.112.045112. View

Allen J, Wolf D, George M, Hester S, Sun G, Thai S . Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Toxicol Pathol. 2006; 34(7):853-62. DOI: 10.1080/01926230601047816. View

Attema B, Janssen A, Rijkers D, van Schothorst E, Hooiveld G, Kersten S . Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice. Mol Metab. 2022; 66:101602. PMC: 9526138. DOI: 10.1016/j.molmet.2022.101602. View

Bhat V, Hester S, Nesnow S, Eastmond D . Concordance of transcriptional and apical benchmark dose levels for conazole-induced liver effects in mice. Toxicol Sci. 2013; 136(1):205-15. DOI: 10.1093/toxsci/kft182. View

Bitter A, Rummele P, Klein K, Kandel B, Rieger J, Nussler A . Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms. Arch Toxicol. 2014; 89(11):2089-103. DOI: 10.1007/s00204-014-1348-x. View

Blumberg B, Sabbagh Jr W, Juguilon H, Bolado Jr J, van Meter C, Ong E . SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 1998; 12(20):3195-205. PMC: 317212. DOI: 10.1101/gad.12.20.3195. View

Bourgon R, Gentleman R, Huber W . Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A. 2010; 107(21):9546-51. PMC: 2906865. DOI: 10.1073/pnas.0914005107. View

Calkin A, Tontonoz P . Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol. 2012; 13(4):213-24. PMC: 3597092. DOI: 10.1038/nrm3312. View

Carazo A, Dusek J, Holas O, Skoda J, Hyrsova L, Smutny T . Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) Signaling. Front Pharmacol. 2018; 9:993. PMC: 6193428. DOI: 10.3389/fphar.2018.00993. View

10.

Chavez-Talavera O, Tailleux A, Lefebvre P, Staels B . Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017; 152(7):1679-1694.e3. DOI: 10.1053/j.gastro.2017.01.055. View

11.

Currie R, Peffer R, Goetz A, Omiecinski C, Goodman J . Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action. Toxicology. 2014; 321:80-8. PMC: 4089507. DOI: 10.1016/j.tox.2014.03.003. View

12.

Dauwe Y, Mary L, Oliviero F, Grimaldi M, Balaguer P, Gayrard V . Steatosis and Metabolic Disorders Associated with Synergistic Activation of the CAR/RXR Heterodimer by Pesticides. Cells. 2023; 12(8). PMC: 10137125. DOI: 10.3390/cells12081201. View

13.

Anastassiadou M, Bernasconi G, Brancato A, Carrasco Cabrera L, Ferreira L, Greco L . Evaluation of confirmatory data following the Article 12 MRL review for propiconazole. EFSA J. 2021; 19(2):e06405. PMC: 7863007. DOI: 10.2903/j.efsa.2021.6405. View

14.

Elcombe C, Peffer R, Wolf D, Bailey J, Bars R, Bell D . Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol. 2013; 44(1):64-82. PMC: 4019974. DOI: 10.3109/10408444.2013.835786. View

15.

Fragki S, Dirven H, Fletcher T, Grasl-Kraupp B, Gutzkow K, Hoogenboom R . Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?. Crit Rev Toxicol. 2021; 51(2):141-164. DOI: 10.1080/10408444.2021.1888073. View

16.

Frankish A, Diekhans M, Ferreira A, Johnson R, Jungreis I, Loveland J . GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2018; 47(D1):D766-D773. PMC: 6323946. DOI: 10.1093/nar/gky955. View

17.

Ghisari M, Long M, Tabbo A, Bonefeld-Jorgensen E . Effects of currently used pesticides and their mixtures on the function of thyroid hormone and aryl hydrocarbon receptor in cell culture. Toxicol Appl Pharmacol. 2015; 284(3):292-303. DOI: 10.1016/j.taap.2015.02.004. View

18.

Goetz A, Dix D . Toxicogenomic effects common to triazole antifungals and conserved between rats and humans. Toxicol Appl Pharmacol. 2009; 238(1):80-9. DOI: 10.1016/j.taap.2009.04.016. View

19.

Grun F, Blumberg B . Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology. 2006; 147(6 Suppl):S50-5. DOI: 10.1210/en.2005-1129. View

20.

Gwag T, Meng Z, Sui Y, Helsley R, Park S, Wang S . Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. J Hepatol. 2019; 70(5):930-940. PMC: 6462244. DOI: 10.1016/j.jhep.2018.12.038. View